4.2 Article

Topoisomerase IIβ immunoreactivity (IR) co-localizes with neuronal marker-IR but not glial fibrillary acidic protein-IR in GLI3-positive medulloblastomas: an immunohistochemical analysis of 124 medulloblastomas from the Japan Children's Cancer Group

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated Medulloblastoma

Manabu Natsumeda et al.

Summary: The study shows that GLI3 is highly expressed in both WNT-activated and SHH-activated medulloblastoma, with GLI1 and GLI3 being highly expressed in SHH-activated medulloblastoma. In contrast, GLI3 is significantly expressed in WNT-activated medulloblastoma while GLI1 is suppressed.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2021)

Article Multidisciplinary Sciences

Resolving medulloblastoma cellular architecture by single-cell genomics

Volker Hovestadt et al.

NATURE (2019)

Article Oncology

A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma

Soledad Gomez et al.

CLINICAL CANCER RESEARCH (2018)

Review Biochemistry & Molecular Biology

Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives

Jessica Marinello et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Biochemistry & Molecular Biology

Topoisomerases and Anthracyclines: Recent Advances and Perspectives in Anticancer Therapy and Prevention of Cardiotoxicity

Alvaro Mordente et al.

CURRENT MEDICINAL CHEMISTRY (2017)

Article Oncology

Intertumoral Heterogeneity within Medulloblastoma Subgroups

Florence M. G. Cavalli et al.

CANCER CELL (2017)

Article Multidisciplinary Sciences

Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma

Itay Tirosh et al.

NATURE (2016)

Article Clinical Neurology

Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples

Paul A. Northcott et al.

ACTA NEUROPATHOLOGICA (2012)

Article Multidisciplinary Sciences

Target genes of Topoisomerase IIβ regulate neuronal survival and are defined by their chromatin state

Vijay K. Tiwari et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Clinical Neurology

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

David W. Ellison et al.

ACTA NEUROPATHOLOGICA (2011)

Article Oncology

Medulloblastoma Comprises Four Distinct Molecular Variants

Paul A. Northcott et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Clinical Neurology

Induction of autophagy in temozolomide treated malignant gliomas

Manabu Natsumeda et al.

NEUROPATHOLOGY (2011)

Review Oncology

Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification

William R. Polkinghorn et al.

NATURE CLINICAL PRACTICE ONCOLOGY (2007)

Article Biochemistry & Molecular Biology

Role of topoisomerase IIβ in the expression of developmentally regulated genes

Yi Lisa Lyu et al.

MOLECULAR AND CELLULAR BIOLOGY (2006)

Article Clinical Neurology

Stratification of medulloblastoma on the basis of histopathological grading

Felice Giangaspero et al.

ACTA NEUROPATHOLOGICA (2006)

Review Anatomy & Morphology

Expression dynamics and functional implications of DNA topoisomerase II beta in the brain

Kimiko M. Tsutsui et al.

ANATOMICAL SCIENCE INTERNATIONAL (2006)

Article Clinical Neurology

Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas

CS McManamy et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)

Article Clinical Neurology

Large cell/anaplastic medulloblastomas: A Pediatric Oncology Group study

HG Brown et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)

Article Multidisciplinary Sciences

DNA topoisomerase IIβ and neural development

X Yang et al.

SCIENCE (2000)